VF
UTMD icon

Virtu Financial’s Utah Medical Products UTMD Stock Holding History

Virtu Financial’s Portfolio UTMD Stock Details UTMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-3,088
Closed -$207K – 2088
2024
Q3 		$207K Buy
+3,088
New +$210K 0.01% 786
2024
Q2 		– Sell
-4,463
Closed -$317K – 1908
2024
Q1 		$317K Buy
+4,463
New +$335K 0.02% 595

Other funds holding UTMD

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Virtu Financial's UTMD Position: Q4 2024 in Review

Virtu Financial sold out of Utah Medical Products (UTMD) in Q4 2024, closing a stake of 3,088 shares — an estimated $207K sold.

Virtu Financial first reported a position in UTMD in Q1 2024 and held it in 2 quarters. The position peaked at $317K in Q1 2024. 112 funds tracked by Wall St. Rank hold UTMD as of Q4 2024.

  • Virtu Financial reported no remaining Utah Medical Products position as of Q4 2024 after selling out during the quarter.
  • Virtu Financial sold 3,088 Utah Medical Products shares in Q4 2024, an estimated $207K.
  • Virtu Financial first reported a position in Utah Medical Products in Q1 2024 and held it in 2 quarters.
  • Virtu Financial's Utah Medical Products position peaked at $317K in Q1 2024.
  • 112 funds tracked by Wall St. Rank held Utah Medical Products as of Q4 2024.

Based on Virtu Financial's 13F filing for Q4 2024, filed 11 Feb 2025.